Nureca Limited (NURECA) — Board Meeting | 21 July 2026

StockFin.ai

Try Free

📢 Key Event
Board approved unaudited Q1 FY26-27 financial results

💡 Investor Takeaway
The company posted strong revenue growth and profitability, signaling positive near-term performance.

Nureca Limited announced the unaudited standalone and consolidated financial results for Q1 FY26-27 ended June 30, 2026, showing revenue of ₹423.14 crores, a net profit of ₹24.32 crores, and EPS of [amount context mismatch]. The Board approved the results, confirmed no material misstatements, and noted ongoing merger of Nureca Technologies. The filing includes auditor review and compliance with SEBI regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NURECA ✨ Ask AI About This

About Nureca Limited (NURECA)

Healthcare · Healthcare Equipment & Supplies · Listed on NSE

Market Cap: ₹260.49 Cr P/E: -47.3

View full NURECA stock details →

📡 Get AI alerts when NURECA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NURECA — Free

💡 Ask AI about this filing

"How does Q1 revenue compare to analysts' expectations?" "What is the expected timeline for the merger completion?" "What is the projected EPS trend for the next quarter?"

Ask AI Free →

📊 More NURECA filings

See all NURECA filings →

🔥 Also filed on 21 July 2026

AARTIIND Aarti Industries Limited Financial Results ANTHEM Anthem Biosciences Limited Financial Results MUFIN Mufin Green Finance Limited Corporate Action ABCAPITAL Aditya Birla Capital Limited Announcement CYIENTDLM Cyient DLM Limited Financial Results KIOCL KIOCL Limited Insider Trading

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when NURECA files new disclosures

Track NURECA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NURECA — Free

Free account · 2 AI queries/day